Market Research Report
Global Biosimilars Market 2016-2020
|Published by||TechNavio (Infiniti Research Ltd.)||Product code||232659|
|Published||Content info||152 Pages
|Global Biosimilars Market 2016-2020|
|Published: August 1, 2016||Content info: 152 Pages||
Biosimilars are defined as the follow-on versions of original biological medicines. These are separately developed after the patent protecting the original product has expired. Biosimilars are intended to have the same MOA as original biological drugs and are designed to treat the same diseases as the innovator's product. They have many similarities, but are not identical to, the reference biopharmaceutical product.
Technavio's analysts forecast the global biosimilars market to grow at a CAGR of 55.52% during the period 2016-2020.
The report covers the present scenario and the growth prospects of the global biosimilars market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sale of products such as somatropin, erythropoietin, colony-stimulating factors (CSF), interferons, interleukins, insulin and insulin analogs, follicle stimulating hormones (FSH), monoclonal antibodies (mAbs), and low molecular weight heparins (LMWH).
The market is divided into the following segments based on geography:
Technavio's report, Global Biosimilars Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.